Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?

Çakmak, Semih; Demir, Gokhan; Tunç, Uğur; Sukun, Elmas Yuksel; Akbas, Yusuf Berk; Ozkaya, Abdullah; Artunay, Ozgur; Erdogan, Gurkan

doi:10.5935/0004-2749.2023-0229

Contact

Submission

Youtube

Open Access

Peer-Reviewed
Artigo Original

Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?

Semih Çakmak¹; Gokhan Demir²; Uğur Tunç³; Elmas Yuksel Sukun⁴; Yusuf Berk Akbas⁵; Abdullah Ozkaya⁶; Ozgur Artunay⁷; Gurkan Erdogan¹

DOI: 10.5935/0004-2749.2023-0229

1. Department of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
2. Department of Ophthalmology, Westeye Hospital, Erbil, Iraq
3. Department of Ophthalmology, Eyup State Hospital, Istanbul, Turkey
4. Alanya Training and Research Hospital, Antalya, Turkey
5. Başakşehir Çam and Sakura Training and Research Hospital, Istanbul, Turkey
6. Department of Ophthalmology, Memorial Sisli Hospital, Istanbul, Turkey
7. Beyoglu Training and Research Hospital, Istanbul, Turkey

Corresponding author

Semih Çakmak
E-mail: [email protected]